Background Although several therapeutic agents have been evaluated for the treatment of
coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be …

Noroviruses are the most common cause of viral gastroenteritis in the United States. To
determine the magnitude and duration of virus shedding in feces, we evaluated persons who …

BACKGROUND: Although several therapeutic agents have been evaluated for the treatment
of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be …

Background Although the three vaccines against coronavirus disease 2019 (Covid-19) that
have received emergency use authorization in the United States are highly effective, …

The major barrier to research and development of effective interventions for human noroviruses
(HuNoVs) has been the lack of a robust and reproducible in vitro cultivation system. …

Omicron Neutralization and mRNA-1273 Boosters Neutralization of the omicron variant was
assessed in serum samples obtained from persons who had received an mRNA-1273 …

Background Severe acute respiratory syndrome (SARS) emerged in China in 2002 and
spread to other countries before brought under control. Because of a concern for reemergence …

ContextWhile hospitalization rates have declined overall, hospitalizations for acute lower
respiratory tract infections have increased steadily since 1980. Development of new …

Noroviruses (NoVs) are a leading cause of gastroenteritis worldwide and are recognized as
the foremost cause of foodborne illness. Despite numerous efforts, routine cell cultures have …

Background Safe and effective antiviral agents are needed to prevent infection with influenza
A and B viruses. Oseltamivir (GS4104), which can be administered orally, is the prodrug of …